Broad Institute takes a hit in European CRISPR patent struggle – Science Magazine
Science Magazine |
Broad Institute takes a hit in European CRISPR patent struggle
Science Magazine A decision from the European Patent Office (EPO) has put the Broad Institute in Cambridge, Massachusetts, on shaky ground with its intellectual property claims to the gene-editing tool CRISPR. EPO yesterday revoked a patent granted to the Broad for … UPDATE: Rockefeller, Broad Settle CRISPR IP Dispute; EPO Denies Broad European PatentGenomeWeb CRISPR: the gene editing tool making the world go roundLexology Mixed views on Broad’s fate after EPO revokes CRISPR patentLife Sciences Intellectual Property Review The Pharma Letter all 4 news articles » |
|
First human CRISPR study in the US could begin soon
Engadget The Penn scientists won’t be injecting CRISPR directly into patients’ bloodstreams; Instead, they’ll use a method called ex vivo gene therapy, extracting blood and editing it with CRISPR before re-inserting it into subjects. This may bypass certain … |